Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,708.80
(
1.16%
)
US TECH 100
24,043.97
(
1.24%
)
Dow Jones
46,988.54
(
0.92%
)
Brent Oil
97.54
(
-3.65%
)
Bitcoin
74,230.00
(
1.95%
)
News Focus
News Focus
Post# of 257246
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122788
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 146651

Monday, 08/06/2012 12:50:39 PM

Monday, August 06, 2012 12:50:39 PM

Post# of 257246
Biotech-Partnership Buyouts (updated)

Many drug/biotech partnerships eventually result in buyout offers.
Here are a few examples in descending order of buyout premium
(thanks to jq1234 for contributing additional cases): 
 
 Roche-MEMY  319% 
 PFE  -COLY  167% 
 PFE  -ICGN  150% 
 LLY  -SGXP  119% 
 PFE  -ENCY  118% 
 GSK  -HGSI   99% 
 NVS  -Spdel  94% 
 BMY  -MEDX   90% 
 BMY  -ZGEN   84% 
 BIIB -FACT   64% (outbid by ABT) 
 JNJ  -CRXL   58% 
 LLY  -ICOS   54% 
 AMGN -ABGX   54% 
 BMY  -IMCL   51% (outbid by LLY) 
 MRK  -SGP    34% 
 AMGN -MITI   33%

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now